Sponsor
Organogenesis
Clinical research sponsor
Clinical trials
9 shownA Study to Evaluate the Efficacy of a Purified Native Type 1 Collagen Extracellular Matrix With Polyhexamethylene Biguanide Antimicrobial (PCMP) and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot UlcersNCT06618612 · lead sponsor · 2024-08-19
RECRUITINGRandomized Clinical Study Assessing NuShield Versus Standard of Care in Diabetic Foot UlcersNCT03855514 · lead sponsor · 2019-02-08
UNKNOWNAffinity Prospective Diabetic Foot Trial Crossover GroupNCT03205436 · lead sponsor · 2017-05-01
COMPLETEDEffect of Fresh Amniotic Membrane in the Treatment of Diabetic Foot UlcersNCT02880592 · lead sponsor · 2016-08-01
COMPLETEDApligraf Versus Standard Therapy in the Treatment of Diabetic Foot UlcersNCT00512538 · lead sponsor · 2000-10-01
TERMINATEDPivotal Trial of Dermagraft(R) to Treat Diabetic Foot UlcersNCT01181453 · lead sponsor · 1998-12-01
COMPLETEDDermagraft(R) for the Treatment of Patients With Diabetic Foot UlcersNCT01181440 · lead sponsor · 1994-09-01
COMPLETEDNuShield/Affinity for the Treatment of Neuropathic Diabetic Foot UlcersNCT02461641 · collaborator · 2015-03-01
COMPLETEDClinical Evaluation of the Combined Use of Apligraf® and the SNaP® Pressure Wound Therapy SystemNCT01623882 · collaborator · 2012-06-01
WITHDRAWNSponsor roles
lead sponsor7
collaborator2
How to interpret this record
CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.